These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31974674)

  • 1. Dynamic changes of views on the brain changes of Cushing's syndrome using different computer-assisted tool.
    Gao L; Liu L; Shi L; Luo Y; Wang Z; Guo X; Xing B
    Rev Endocr Metab Disord; 2020 Mar; 21(1):185-200. PubMed ID: 31974674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural brain abnormalities in Cushing's syndrome.
    Bauduin SEEC; van der Wee NJA; van der Werff SJA
    Curr Opin Endocrinol Diabetes Obes; 2018 Aug; 25(4):285-289. PubMed ID: 29746308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible and the irreversible structural alterations on brain after resolution of hypercortisolism in Cushing's disease.
    Jiang H; Liu C; Pan SJ; Ren J; He NY; Sun YH; Bian LG; Yan FH; Yang WJ; Sun QF
    Steroids; 2019 Nov; 151():108457. PubMed ID: 31326450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive function and cerebral assessment in patients who have Cushing's syndrome.
    Bourdeau I; Bard C; Forget H; Boulanger Y; Cohen H; Lacroix A
    Endocrinol Metab Clin North Am; 2005 Jun; 34(2):357-69, ix. PubMed ID: 15850847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent thromboembolism as a hallmark of Cushing's syndrome.
    La Brocca A; Terzolo M; Pia A; Paccotti P; De Giuli P; Angeli A
    J Endocrinol Invest; 1997 Apr; 20(4):211-4. PubMed ID: 9211128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in cognitive impairment following the successful treatment of endogenous Cushing's syndrome-a case report and literature review.
    Brzozowska MM; Kepreotis S; Tsang F; Fuentes-Patarroyo SX
    BMC Endocr Disord; 2019 Jun; 19(1):68. PubMed ID: 31253144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of Cushing's disease.
    Fehm HL; Voigt KH
    Pathobiol Annu; 1979; 9():225-55. PubMed ID: 225710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies.
    Andela CD; van Haalen FM; Ragnarsson O; Papakokkinou E; Johannsson G; Santos A; Webb SM; Biermasz NR; van der Wee NJ; Pereira AM
    Eur J Endocrinol; 2015 Jul; 173(1):R1-14. PubMed ID: 25650405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional brain alterations in Cushing's syndrome.
    Papakokkinou E; Ragnarsson O
    Front Endocrinol (Lausanne); 2023; 14():1163482. PubMed ID: 37152946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral atrophy in Cushing's disease.
    Simmons NE; Do HM; Lipper MH; Laws ER
    Surg Neurol; 2000 Jan; 53(1):72-6. PubMed ID: 10697236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism (Cushing's syndrome) from physiologic/non-neoplastic hypercortisolism (formerly known as pseudo-Cushing's syndrome).
    Findling JW; Raff H
    Eur J Endocrinol; 2017 May; 176(5):R205-R216. PubMed ID: 28179447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease.
    Devoe DJ; Miller WL; Conte FA; Kaplan SL; Grumbach MM; Rosenthal SM; Wilson CB; Gitelman SE
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3196-202. PubMed ID: 9329338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and diagnosis of Cushing's syndrome.
    Miyachi Y
    Biomed Pharmacother; 2000 Jun; 54 Suppl 1():113s-117s. PubMed ID: 10915006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cushing's syndrome due to intermittent ectopic ACTH production showing a temporary remission during a pulmonary infection.
    Peri A; Bemporad D; Parenti G; Luciani P; Serio M; Mannelli M
    Eur J Endocrinol; 2001 Nov; 145(5):605-11. PubMed ID: 11720879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's disease.
    Aron DC; Findling JW; Tyrrell JB
    Endocrinol Metab Clin North Am; 1987 Sep; 16(3):705-30. PubMed ID: 2826137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal medulla secretion in Cushing's syndrome.
    Mannelli M; Lanzillotti R; Pupilli C; Ianni L; Conti A; Serio M
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1331-5. PubMed ID: 8200934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EEG sleep in Cushing's disease and Cushing's syndrome: comparison with patients with major depressive disorder.
    Shipley JE; Schteingart DE; Tandon R; Pande AC; Grunhaus L; Haskett RF; Starkman MN
    Biol Psychiatry; 1992 Jul; 32(2):146-55. PubMed ID: 1330006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metabolite abnormalities in ventromedial prefrontal cortex are related to duration of hypercortisolism and anxiety in patients with Cushing's syndrome.
    Crespo I; Santos A; Gómez-Ansón B; López-Mourelo O; Pires P; Vives-Gilabert Y; Webb SM; Resmini E
    Endocrine; 2016 Sep; 53(3):848-56. PubMed ID: 27103571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
    Cortet B; Cortet C; Blanckaert F; d'Herbomez M; Marchandise X; Wémeau J-L ; Decoulx M; Dewailly D
    Osteoporos Int; 2001; 12(2):117-23. PubMed ID: 11303711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism.
    Bourdeau I; Bard C; Noël B; Leclerc I; Cordeau MP; Bélair M; Lesage J; Lafontaine L; Lacroix A
    J Clin Endocrinol Metab; 2002 May; 87(5):1949-54. PubMed ID: 11994323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.